US 11472808
Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
granted A61KA61K45/06
Quick answer
US patent 11472808 (Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K45/06